Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamapimod in Active Rheumatoid Arthritis on Stable Methotrexate
NCT00316771Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of pamapimod in rheumatoid arthritis (RA), sponsored by Roche. Started Nov 2005; status: completed.
02
Drugs
pamapimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00316771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316771.